Lawrence Mwananyanda1,2,3, Christopher J Gill2,1, William MacLeod2, Geoffrey Kwenda4, Rachel Pieciak2, Zachariah Mupila5, Rotem Lapidot6, Francis Mupeta7, Leah Forman8, Luunga Ziko7, Lauren Etter2, Donald Thea2. 1. Contributed equally. 2. Department of Global Health, Boston University School of Public Health, Boston, MA 02118, USA. 3. Right To Care - Zambia. 4. Department of Biomedical Sciences, University of Zambia, Lusaka, Zambia. 5. ZPRIME Molecular Laboratory, University Teaching Hospital, Lusaka, Zambia. 6. Department of Global Health, Boston University School of Public Health, Boston, MA, USA. 7. Division of Internal Medicine, Infectious Diseases Section, University Teaching Hospital, Lusaka, Zambia. 8. Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA.
Abstract
OBJECTIVE: To directly measure the fatal impact of coronavirus disease 2019 (covid-19) in an urban African population. DESIGN: Prospective systematic postmortem surveillance study. SETTING: Zambia's largest tertiary care referral hospital. PARTICIPANTS: Deceased people of all ages at the University Teaching Hospital morgue in Lusaka, Zambia, enrolled within 48 hours of death. MAIN OUTCOME MEASURE: Postmortem nasopharyngeal swabs were tested via reverse transcriptase quantitative polymerase chain reaction (PCR) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Deaths were stratified by covis-19 status, location, age, sex, and underlying risk factors. RESULTS: 372 participants were enrolled between June and September 2020; PCR results were available for 364 (97.8%). SARS-CoV-2 was detected in 58/364 (15.9%) according to the recommended cycle threshold value of <40 and in 70/364 (19.2%) when expanded to any level of PCR detection. The median age at death among people with a positive test for SARS-CoV-2 was 48 (interquartile range 36-72) years, and 69% (n=48) were male. Most deaths in people with covid-19 (51/70; 73%) occurred in the community; none had been tested for SARS-CoV-2 before death. Among the 19/70 people who died in hospital, six were tested before death. Among the 52/70 people with data on symptoms, 44/52 had typical symptoms of covid-19 (cough, fever, shortness of breath), of whom only five were tested before death. Covid-19 was identified in seven children, only one of whom had been tested before death. The proportion of deaths with covid-19 increased with age, but 76% (n=53) of people who died were aged under 60 years. The five most common comorbidities among people who died with covid-19 were tuberculosis (22; 31%), hypertension (19; 27%), HIV/AIDS (16; 23%), alcohol misuse (12; 17%), and diabetes (9; 13%). CONCLUSIONS: Contrary to expectations, deaths with covid-19 were common in Lusaka. Most occurred in the community, where testing capacity is lacking. However, few people who died at facilities were tested, despite presenting with typical symptoms of covid-19. Therefore, cases of covid-19 were under-reported because testing was rarely done not because covid-19 was rare. If these data are generalizable, the impact of covid-19 in Africa has been vastly underestimated. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: To directly measure the fatal impact of coronavirus disease 2019 (covid-19) in an urban African population. DESIGN: Prospective systematic postmortem surveillance study. SETTING: Zambia's largest tertiary care referral hospital. PARTICIPANTS: Deceased people of all ages at the University Teaching Hospital morgue in Lusaka, Zambia, enrolled within 48 hours of death. MAIN OUTCOME MEASURE: Postmortem nasopharyngeal swabs were tested via reverse transcriptase quantitative polymerase chain reaction (PCR) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Deaths were stratified by covis-19 status, location, age, sex, and underlying risk factors. RESULTS: 372 participants were enrolled between June and September 2020; PCR results were available for 364 (97.8%). SARS-CoV-2 was detected in 58/364 (15.9%) according to the recommended cycle threshold value of <40 and in 70/364 (19.2%) when expanded to any level of PCR detection. The median age at death among people with a positive test for SARS-CoV-2 was 48 (interquartile range 36-72) years, and 69% (n=48) were male. Most deaths in people with covid-19 (51/70; 73%) occurred in the community; none had been tested for SARS-CoV-2 before death. Among the 19/70 people who died in hospital, six were tested before death. Among the 52/70 people with data on symptoms, 44/52 had typical symptoms of covid-19 (cough, fever, shortness of breath), of whom only five were tested before death. Covid-19 was identified in seven children, only one of whom had been tested before death. The proportion of deaths with covid-19 increased with age, but 76% (n=53) of people who died were aged under 60 years. The five most common comorbidities among people who died with covid-19 were tuberculosis (22; 31%), hypertension (19; 27%), HIV/AIDS (16; 23%), alcohol misuse (12; 17%), and diabetes (9; 13%). CONCLUSIONS: Contrary to expectations, deaths with covid-19 were common in Lusaka. Most occurred in the community, where testing capacity is lacking. However, few people who died at facilities were tested, despite presenting with typical symptoms of covid-19. Therefore, cases of covid-19 were under-reported because testing was rarely done not because covid-19 was rare. If these data are generalizable, the impact of covid-19 in Africa has been vastly underestimated. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Alvin X Han; Amy Toporowski; Jilian A Sacks; Mark Perkins; Sylvie Briand; Maria van Kerkhove; Emma Hannay; Sergio Carmona; Bill Rodriguez; Edyth Parker; Brooke E Nichols; Colin A Russell Journal: medRxiv Date: 2022-05-23
Authors: Kirsten E Wiens; Pinyi Nyimol Mawien; John Rumunu; Damien Slater; Forrest K Jones; Serina Moheed; Andrea Caflisch; Bior K Bior; Iboyi Amanya Jacob; Richard Lino Lako; Argata Guracha Guyo; Olushayo Oluseun Olu; Sylvester Maleghemi; Andrew Baguma; Juma John Hassen; Sheila K Baya; Lul Deng; Justin Lessler; Maya N Demby; Vanessa Sanchez; Rachel Mills; Clare Fraser; Richelle C Charles; Jason B Harris; Andrew S Azman; Joseph F Wamala Journal: Emerg Infect Dis Date: 2021-06 Impact factor: 6.883
Authors: Laura Müller; Reida El Oakley; Mohammed Saad; Ali H Mokdad; Giamal A Etolhi; Antoine Flahault Journal: J Glob Health Date: 2021-05-08 Impact factor: 4.413
Authors: Pruthu Thekkur; Kudakwashe C Takarinda; Collins Timire; Charles Sandy; Tsitsi Apollo; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-31
Authors: Mohamed Bailor Barrie; Sulaiman Lakoh; J Daniel Kelly; Joseph Sam Kanu; James Squire; Zikan Koroma; Silleh Bah; Osman Sankoh; Abdulai Brima; Rashid Ansumana; Sarah A Goldberg; Smit Chitre; Chidinma Osuagwu; Justin Maeda; Bernard Barekye; Tamuno-Wari Numbere; Mohammed Abdulaziz; Anthony Mounts; Curtis Blanton; Tushar Singh; Mohamed Samai; Mohamed A Vandi; Eugene T Richardson Journal: medRxiv Date: 2021-07-05